MetLife (MET) Projected to Release Quarterly Earnings on Wednesday

MetLife (NYSE:MET) is projected to announce its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to announce earnings of $2.77 per share and revenue of $19.86 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 9:00 AM ET.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.30 by $0.13. The firm had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the previous year, the company earned $2.02 EPS. The company’s quarterly revenue was up 10.5% compared to the same quarter last year. On average, analysts expect MetLife to post $9.94 EPS for the current fiscal year and $10.72 EPS for the next fiscal year.

MetLife Stock Performance

Shares of NYSE MET opened at $100.08 on Wednesday. The stock’s 50 day moving average price is $97.39 and its two-hundred day moving average price is $85.36. MetLife has a 52-week low of $67.33 and a 52-week high of $103.65.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 3rd will be issued a $0.5925 dividend. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Tuesday, November 3rd.

MetLife announced that its board has initiated a stock buyback plan on Wednesday, August 5th that permits the company to buy back $3 billion in shares. This buyback authorization permits the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Share buyback plans are often an indication that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of research firms have commented on MET. Atlantic Securities set a $103.00 price objective on shares of MetLife in a report on Wednesday, July 15th. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $108.00 to $110.00 and gave the company an “overweight” rating in a research note on Thursday, October 15th. Keefe, Bruyette & Woods raised their price target on shares of MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 11th. UBS Group raised their price target on shares of MetLife from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, October 6th. Finally, Barclays lifted their price target on shares of MetLife from $97.00 to $111.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Thirteen analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, MetLife presently has an average rating of “Moderate Buy” and a consensus price target of $105.44.

MetLife Company Profile

MetLife, Inc (NYSE: MET) is a global financial services company that provides insurance, retirement, and employee benefits solutions to individuals, employers, and institutions. Its offerings include life insurance, dental and vision coverage, accident and disability insurance, annuities, retirement savings products, and related financial services.

Through its institutional and workplace businesses, MetLife helps employers provide benefits and retirement programs to their employees. The company also serves individual customers with protection and income products.